Changes

'''Genentech, Inc.''' is a [[pharmaceutical]] company and one of the world's most financially successful and [[biotechnology]] corporations. Genentech has three drugs that are billion-dollar sellers: Rituxan, for non-Hodgkin's lymphoma; [[Avastin]], for colorectal, non-small cell lung cancers, and treats macular degeneration; and [[Herceptin]] for breast cancer. It also manufactures the lung cancer drug Tarceva. Major customers for its drugs are [[AmerisourceBergen]], [[Cardinal Health]], and [[McKesson]]. The Swiss drug company [[Roche]], which previously owned a majority of stock in the San Francisco based firm, took full ownership in 2009.<ref>[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech], Hoovers, accessed December 2009</ref> According to its website, the company is "considered the founder of the biotechnology industry." <ref>[http://www.gene.com/gene/about/index.html About Us: Leading the Biotechnology Industry], Genentech, accessed July 2007</ref>

{{reflist|2}}